Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
Checking expectations
Motley Fool Returns
Market-beating stocks from our flagship service.
Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 2025-08-29 16:27:07.057818.
Discounted offers are only available to new members. Stock Advisor list price is $199 per year.
Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.
Forest Laboratories (NYSE: FRX) is expected to report Q4 earnings on April 23. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Forest Laboratories's revenues will decrease -23.7% and EPS will contract -76.9%.
The average estimate for revenue is $805.0 million. On the bottom line, the average EPS estimate is $0.18.
Revenue details
Last quarter, Forest Laboratories chalked up revenue of $722.7 million. GAAP reported sales were 40% lower than the prior-year quarter's $1.20 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
Last quarter, non-GAAP EPS came in at -$0.21. GAAP EPS were -$0.58 for Q3 against $1.04 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Recent performance
For the preceding quarter, gross margin was 78.6%, 60 basis points better than the prior-year quarter. Operating margin was -26.6%, much worse than the prior-year quarter. Net margin was -21.4%, much worse than the prior-year quarter.
Looking ahead
The full year's average estimate for revenue is $3.09 billion. The average EPS estimate is $0.40.
Investor sentiment
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Forest Laboratories is outperform, with an average price target of $37.45.